Egophony
WikiDoc Resources for Egophony |
Articles |
---|
Most recent articles on Egophony |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Egophony at Clinical Trials.gov Clinical Trials on Egophony at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Egophony
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Egophony Risk calculators and risk factors for Egophony
|
Healthcare Provider Resources |
Causes & Risk Factors for Egophony |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Egophony (British: Aegophony) is an increased resonance of voice sounds heard when auscultating the lungs, often caused by consolidated or compressed lung tissue due to an infection, pleural effusion, tumor, or congestion. It is due to enhanced transmission of high-frequency noise across fluid, such as in abnormal lung tissue, with lower frequencies filtered out. It results in a high-pitched nasal or bleating quality in the affected person's voice.
While listening to the lungs with a stethoscope, the patient is asked to say the letter "e." What is heard is a higher pitched sound that sounds like the letter "a." (Some doctors refer to this as "e to a changes.") Most commonly, this indicates pneumonia.
Similar terms are bronchophony and whispered pectoriloquy. The mechanism is the same: fluid or consolidation causes the sound of the voice to be transmitted loudly to the periphery of the lungs where it is usually not heard.
Egophony comes from the Greek word for "goat," (aix, aig-) in reference to the bleating quality of the sound. [1]
References
- ↑ Sapira JD (1995). "About egophony". Chest. 108 (3): 865–7. PMID 7656646.